Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (221-230 of 305) with videos related to

Pageof 31
Sort By:
Vaccine|July 16, 2017
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenzaMarc Rondy, Odile Launay, Jesus Castilla, et al.
Metabolism: Clinical and Experimental|February 2, 2023
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohortBénédicte Gaborit, Sara Fernandes, Paul Loubet, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter studyPaul Loubet, Nezha Samih-Lenzi, Florence Galtier, et al.
AIDS (London, England)|December 1, 2012
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapyJean-Marc Lacombe, François Boue, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
BMJ Paediatrics Open|March 5, 2021
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional studyRobert Cohen, Camille Jung, Naim Ouldali, et al.
Open Forum Infectious Diseases|July 17, 2015
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseAnne Benoit, Jiri Beran, Jeanne-Marie Devaster, et al.
Therapie|December 17, 2023
Controlled human infection trials: Legitimacy and conditions of implementation in FranceAnne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 31

Showing results (221-230 of 305) with videos related to

Sort By:
Pageof 31
Vaccine|July 16, 2017
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenzaMarc Rondy, Odile Launay, Jesus Castilla, et al.
Metabolism: Clinical and Experimental|February 2, 2023
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohortBénédicte Gaborit, Sara Fernandes, Paul Loubet, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter studyPaul Loubet, Nezha Samih-Lenzi, Florence Galtier, et al.
AIDS (London, England)|December 1, 2012
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapyJean-Marc Lacombe, François Boue, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
BMJ Paediatrics Open|March 5, 2021
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional studyRobert Cohen, Camille Jung, Naim Ouldali, et al.
Open Forum Infectious Diseases|July 17, 2015
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseAnne Benoit, Jiri Beran, Jeanne-Marie Devaster, et al.
Therapie|December 17, 2023
Controlled human infection trials: Legitimacy and conditions of implementation in FranceAnne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 31